Fasinumab (Anti-Human NGF) is a human IgG4 monoclonal antibody to nerve growth factor (NGF). Fasinumab can be used in acute sciatica and knee osteoarthritis (OA) studies[1].
Molecular Weight:
(144.9 kDa)
Purity:
98.11
CAS Number:
[1190239-42-9]
Target:
Trk Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted